Pharmaceuticals

  • Blog post

    Senate bill would restrict pharmaceutical advertising

    2019-01-11T15:00:00Z

    Senate Democrats are promoting the End Taxpayer Subsidies for Drug Ads Act, legislation that would prohibit pharmaceutical drug manufacturers from claiming tax deductions for consumer advertising expenses.

  • Blog post

    Ellison questions HHS hire from CVS Caremark.

    2018-04-11T12:00:00Z

    Rep. Keith Ellison (D-Minn.) is asking Department of Health and Human Services Secretary Alex Azar for an explanation of the decision to hire CVS Caremark Vice President Daniel Best to lead the agency’s drug pricing reform effort.

  • Article

    Are pharma firms set for increased scrutiny?

    2016-12-06T11:30:00Z

    How pharmaceutical firms price their products is getting a lot of additional attention in the United Kingdom and United States. Neil Hodge reports.

  • Article

    Mitigating FCPA Risks in Pharma, Med Device Sectors

    2015-03-17T14:45:00Z

    Image: SEC Enforcement Director Andrew Ceresney recently dropped new hints on FCPA risks for pharma and medical devices, plus suggestions on how to avoid those risks. “Our FCPA focus obviously covers many industries,” he said. “But the pharma industry is one on which we have been particularly focused in recent ...